#NewAllyAseBio | "AseBio represents the meeting place for all the companies in the biotech... 13/12/2023 Corporate Meet JORI & ARMENGOL, our new ally. We talked to María Sanjuanbenito, ejecutiva de Cuentas. AseBio
#NewAseBioMember | "AseBio is a strong association of public and private organizations inv... 24/11/2023 Corporate Meet BioClonal, our new member. We talked to its with Paula Garfella Founder & CEO and Jessika Valero, CRO. Partners - BIOCLONAL
Sustainable Energy Solutions for Pharma and Biotech 24/11/2023 Climate change Bioeconomy Corporate ZETA is committed to making a positive contribution by delivering innovative and sustainable strategies that help our... Partners
GENESIS Biomed kicks-off its new site at Valencia and holds its Annual Conference 23/11/2023 Corporate GENESIS Biomed inaugurated its new site at Valencia last week at the BioHub VLC, as part of the GENESIS Biomed Annual... Partners - GENESIS Biomed
#NewAseBioAlly | "AseBio is a gateway, a meeting point with and for companies, association... 16/11/2023 Corporate Meet UNGRIA Patentes y Marcas, our new ally. We talked with Sergio Escorza Treviño, director del Departamento de... AseBio
ORYZON to provide corporate progress updates at several events in november 06/11/2023 Corporate Oryzon’s CEO, Dr. Carlos Buesa, will attend the LSX Investival Showcase, to be held on November 13 at at Old... Partners - Oryzon Genomics
ORYZON reports financial results and corporate updates for quarter ended September 30, 202... 30/10/2023 Healthcare Access to innovation Financing Corporate Research and development (R&D) expenses of $3.8 and $12.2 million for the quarter and nine months ended September 30... Partners - Oryzon Genomics
ORYZON to provide corporate progress updates at several events in October 02/10/2023 Corporate Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in... Partners - Oryzon Genomics
HOFFMANN EITLE Madrid & Barcelona celebrate their 10th anniversary in BIOSPAIN 02/10/2023 Corporate As part of BIOSPAIN, from 26 to 28 September in Barcelona, HOFFMANN EITLE Madrid & Barcelona celebrated its tenth... Partners - Hoffmann · Eitle
Oryzon announces completed patient recruitment in the PORTICO Phase IIb trial of vafidemst... 26/07/2023 Corporate Multiple primary endpoints include reduction in agitation and aggression and overall disease improvement. Recent... Partners - Oryzon Genomics
